Finance

Lists
Why is OKUR down 8.37%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
$ 2.41
-8.37%
(-0.22) 1D
10-р сарын 6, 15:51:58 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
$ 2.65
High
$ 2.65
Low
$ 2.41
Mkt. cap
95.00 сая
Avg. vol.
295.40 мян
Volume
284.38 мян
52-wk high
$ 5.38
52-wk low
$ 2.23
EPS
-$ 3.50
Beta
0.12
Shares outstanding
40.50 сая
No. of employees
45
Open
$ 2.65
High
$ 2.65
Low
$ 2.41
Mkt. cap
95.00 сая
Avg. vol.
295.40 мян
Volume
284.38 мян
52-wk high
$ 5.38
52-wk low
$ 2.23
EPS
-$ 3.50
Beta
0.12
Shares outstanding
40.50 сая
No. of employees
45
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
16 минутын өмнө
Tesla And 2 Other Founder Led Stocks To Own
ChartMill
ChartMill
·
53 минутын өмнө
What's going on in today's session
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
HeadquartersБаулдер, Колорадо, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current $ 2.41
$ 21.00 (+771.37%)
Average
$ 17.00 (+605.39%)
Lowest
$ 14.00 (+480.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
$ 14.00
+480.9%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$ 14.00
+480.9%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$ 16.00
+563.9%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$ 21.00
+771.4%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
$ 17.00
+605.4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.92 сая
10.72 сая
11.71 сая
12.61 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.59 сая
3.40 сая
3.91 сая
4.29 сая
Operating expense
15.50 сая
14.12 сая
15.62 сая
16.90 сая
Total operating expenses
15.50 сая
14.12 сая
15.62 сая
16.90 сая
Operating income
-15.50 сая
-14.12 сая
-15.62 сая
-16.90 сая
Other non operating income
-
-
-
-
EBT including unusual items
-14.70 сая
-13.50 сая
-15.16 сая
-15.35 сая
EBT excluding unusual items
-14.70 сая
-13.50 сая
-15.16 сая
-15.35 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.70 сая
-13.50 сая
-15.16 сая
-15.35 сая
Net profit margin
-
-
-
-
Earnings per share
-1.09
-0.99
-1.11
-0.31
Interest and investment income
804.00 мян
628.00 мян
458.00 мян
1.55 сая
Interest expense
-2.00 мян
-6.00 мян
-
-
Net interest expenses
802.00 мян
622.00 мян
458.00 мян
1.55 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.39 сая
-14.02 сая
-15.51 сая
-16.81 сая
Gain or loss from assets sale
2.00 мян
4.00 мян
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс